【摘 要】
：
目的: The chemokine and chemokine receptors are the fuse of migration of a variety of cells in vivo,including white blood cells and cancer cells.And they may be involved in every aspect of primary tumor
【机 构】
：
110001 中国医科大学附属第一医院乳腺外科
【出 处】
：
第十六届全国临床肿瘤学大会暨2013年CSCO学术年会
论文部分内容阅读
目的: The chemokine and chemokine receptors are the fuse of migration of a variety of cells in vivo,including white blood cells and cancer cells.And they may be involved in every aspect of primary tumor growth,invasion and distant metastasis.According to the different structures and functions,chemokine receptors are divided into typical chemokine receptors (GPCRs) and atypical chemokine receptors (ACRs).
其他文献
目的:研究西黄丸对Walker256乳腺癌细胞荷瘤大鼠的抗肿瘤及对相关炎性因子的调节作用,探讨其抗肿瘤作用机制.方法:60只雌性Wistar大鼠,随机抽取10只设为空白对照组,剩余50只建立荷瘤大鼠模型,随机分为:阴性对照组(模型组)、西黄丸高、中、低剂量组和香菇多糖组(阳性对照组),每组10只,按10ml/kg液体量灌胃给药,每天2次,连续14天.
目的:本课题旨在研究激素受体阳性晚期乳腺癌多重解救治疗失败后给予依维莫司联合内分泌治疗的疗效及其影响因素.方法:22例激素受体阳性晚期乳腺癌多重解救治疗失败患者,给予依维莫司联合氟维司群、依西美坦、阿那曲唑(来曲唑)、他莫昔芬(托瑞米芬)等内分泌药物治疗的临床资料,对其临床疗效及影响因素等进行统计分析.
目的: Breast cancer is one of the common malignant tumors of female which the incidence increases with age.In China, according to recent statistics, the incidence of breast cancer has increased steadily
目的:研究西黄丸乙醇提取物对荷瘤大鼠的抗肿瘤作用及其免疫学机制.方法:采用w256乳腺癌细胞建立大鼠荷瘤模型,随机分为7组:正常组,模型对照组,香菇多糖组,西黄丸高剂量组,西黄丸乙醇提取物低、中、高剂量组.
目的: Malignant pleural effusion (MPE) is a frequent complication in breast cancer which severely affected the life quality and survival time of the patients.Despite various chemical agents and biologic
目的:在中医"有故无殒"理论指导下,阐明雌激素受体介导的雷公藤内酯醇抗乳腺癌作用机制,为雷公藤在肿瘤临床的应用提供科学依据.方法:收集本院临床乳腺癌组织标本30例,免疫组化法研究乳腺癌组织、癌周组织与正常组织ERα含量及其比例.
目的: Triple negative breast cancer (TNBC)is defined as tumor lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) amplification,whi
目的: Over-expression of MDR1 is responsible for drug resistance with a variety of anticancer drugs as its substrates.Clinical trials and retrospective analyses showed that estrogen receptor α (Erα)-pos
目的:了解不同种族乳腺癌患者FEC方案辅助化疗耐受性差异及其与化疗药物代谢酶基因多态性、化疗药物代谢动力学及营养状况的关系.方法:选取参与FEC方案药物代谢过程中的20个关键基因的39个SNP作为遗传标记,运用PCR-非变性聚丙烯酰胺凝胶电泳、PCR-限制性片段长度多态分析及测序分析的方法对72例乳腺癌患者进行基因分型,通过高压液相色谱分析方法测定5FU及EPI药物浓度,通过NONMEN软件进行药
目的:通过对新疆30例高风险三阴性乳腺癌BRCA基因突变检测,了解新疆高风险三阴性乳腺癌BRCA基因突变情况及BRCA基因突变者与未突变者的临床病理特征的差异.方法:以新疆30例符合高风险三阴性乳腺癌标准的患者为研究对象,通过外周静脉血提取基因组DNA,对BRCA1/2基因的全部编码序列进行扩增.